Return On Equity of Surface Oncology, Inc. from 30 Sep 2018 to 30 Jun 2023
- Taxonomy & unit
- ratio: %
- Description
- Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
- Summary
-
Surface Oncology, Inc. quarterly and annual Return On Equity in % history and change rate from 30 Sep 2018 to 30 Jun 2023.
- Surface Oncology, Inc. Return On Equity for the quarter ending 30 Jun 2023 was -112%, a 132% decline year-over-year.
- Surface Oncology, Inc. annual Return On Equity for 2022 was -53%, a 5.7% increase from 2021.
- Surface Oncology, Inc. annual Return On Equity for 2021 was -56%, a 200% decline from 2020.
- Surface Oncology, Inc. annual Return On Equity for 2020 was 56%.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)
Surface Oncology, Inc. Quarterly Return On Equity (%)
| Period | Value | YoY Chg | Change % | Start Date | End Date |
|---|---|---|---|---|---|
| Q2 2023 | -112% | -64% | -132% | 01 Apr 2023 | 30 Jun 2023 |
| Q1 2023 | -88% | -46% | -111% | 01 Jan 2023 | 31 Mar 2023 |
| Q4 2022 | -53% | +3.2% | +5.7% | 01 Oct 2022 | 31 Dec 2022 |
| Q3 2022 | -53% | -61% | -705% | 01 Jul 2022 | 30 Sep 2022 |
| Q2 2022 | -48% | -61% | -488% | 01 Apr 2022 | 30 Jun 2022 |
| Q1 2022 | -42% | -59% | -345% | 01 Jan 2022 | 31 Mar 2022 |
| Q4 2021 | -56% | -113% | -200% | 01 Oct 2021 | 31 Dec 2021 |
| Q3 2021 | 8.7% | +38% | 01 Jul 2021 | 30 Sep 2021 | |
| Q2 2021 | 12% | +45% | 01 Apr 2021 | 30 Jun 2021 | |
| Q1 2021 | 17% | +55% | 01 Jan 2021 | 31 Mar 2021 | |
| Q4 2020 | 56% | +127% | 01 Oct 2020 | 31 Dec 2020 | |
| Q3 2020 | -30% | +19% | +39% | 01 Jul 2020 | 30 Sep 2020 |
| Q2 2020 | -33% | +12% | +26% | 01 Apr 2020 | 30 Jun 2020 |
| Q1 2020 | -38% | +0.52% | +1.3% | 01 Jan 2020 | 31 Mar 2020 |
| Q4 2019 | -71% | -62% | -729% | 01 Oct 2019 | 31 Dec 2019 |
| Q3 2019 | -49% | +1.6% | +3.2% | 01 Jul 2019 | 30 Sep 2019 |
| Q2 2019 | -45% | 01 Apr 2019 | 30 Jun 2019 | ||
| Q1 2019 | -39% | 01 Jan 2019 | 31 Mar 2019 | ||
| Q4 2018 | -8.5% | 01 Oct 2018 | 31 Dec 2018 | ||
| Q3 2018 | -50% | 01 Jul 2018 | 30 Sep 2018 |
Surface Oncology, Inc. Annual Return On Equity (%)
| Period | Value | YoY Chg | Change % | Start Date | End Date |
|---|---|---|---|---|---|
| 2022 | -53% | +3.2% | +5.7% | 01 Jan 2022 | 31 Dec 2022 |
| 2021 | -56% | -113% | -200% | 01 Jan 2021 | 31 Dec 2021 |
| 2020 | 56% | +127% | 01 Jan 2020 | 31 Dec 2020 | |
| 2019 | -71% | -62% | -729% | 01 Jan 2019 | 31 Dec 2019 |
| 2018 | -8.5% | 01 Jan 2018 | 31 Dec 2018 |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.